// App-Quantinova.ai

: DNMT3A and TET2 Mutations: Linking Genetics and Epigenetics in Pulmonary Arterial Hypertension

Researchers

Presenter

  • F. Potus

Principal Investigators

  • E. K. Cook

  • A. Hsieh

  • M. Pauciulo

  • C. Welch

  • N. Zhu

  • L. Tian

  • P. Lima

  • C. DArsigny

  • Y. Shen

  • P. M. Hassoun

  • W. C. Nichols

  • W. K. Chung

  • M. J. Rauh

  • S. L. Archer

Medical Centers

  • School of Computing, Queens University, Kingston, ON, Canada

  • Columbia University, New York, New York, United States

  • Neohrology , Cincinnati Childrens Hospital Medical Center, Cincinnati, United States

  • Columbia University, New York, New York, United States

  • School of Computing, Queens University, Kingston, ON, Canada

  • Div of Pulm and Crit Care, Johns Hopkins Univ School of Med, Baltimore, MD, United States,

  • Division of Human Genetics, Cincinnati Children’s Hospital Cincinnati OH United States

  • medecine, Columbia university, New york, NY, Canada,

  • GIDRU, Queen's University, Kingston, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • DNA methyltransferase 3 alpha

  • Tet methylcytosine dioxygenase 2

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved